AI Tools Are Becoming the First Stop for Rare Disease Diagnosis
Source: The Wall Street Journal (paywall)
Face2Gene and similar phenotyping platforms are shifting diagnostic workflows by letting patients and families run initial scans before or alongside specialist consultations, compressing what used to be years of trial-and-error medical visits into weeks. Rare diseases are where human doctors are weakest: individual physicians see them so infrequently that pattern recognition fails, but AI trained on millions of genetic databases can flag syndromes from photos and symptom clusters. The friction emerging now is medical authority. Hospitals and insurance systems must reconcile AI findings that sometimes outpace their own specialists' knowledge.